Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.19 USD | -2.06% | +1.83% | +10.43% |
May. 14 | Aprea Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 02 | Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza as Chief Medical Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.43% | 28.77M | |
+51.95% | 63.85B | |
-2.46% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.46% | 26.52B | |
-21.47% | 18.69B | |
+2.85% | 12.73B | |
+22.13% | 12.11B | |
+27.74% | 12.07B |
- Stock Market
- Equities
- APRE Stock
- News Aprea Therapeutics, Inc.
- Aprea Therapeutics Names John Hamill CFO; Shares Rise Early